A Unique Clinical Presentation of X-Linked Lymphoproliferative Syndrome With a Novel Mutation in SH2D1A and Review of the Literature

被引:1
作者
Eckrich, Michael J. [1 ]
Yang, Elizabeth [1 ]
Domm, Jennifer [1 ]
Ho, Richard [1 ]
Calder, Cassie [1 ]
Manes, Becky [1 ]
Bleesing, Jack [2 ]
Frangoul, Haydar [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Pediat, Div Hematol Oncol, Nashville, TN 37232 USA
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
关键词
X-linked lymphoproliferative syndrome; SAP mutation; unrelated donor transplant; EPSTEIN-BARR-VIRUS; HUMORAL IMMUNE-RESPONSES; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; MISSENSE MUTATIONS; DISEASE; INFECTION; DEFICIENCY; PROTEIN; SLAM; SAP;
D O I
10.1097/MPH.0b013e3181e75747
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
X-linked lymphoproliferative syndrome is a well-described syndrome often characterized by progression to fatal infectious mononucleosis. Many mutations of the SH2D1A gene have been identified in patients with X-linked lymphoproliferative syndrome. These mutations are often associated with either decreased or impaired function of the protein product, signaling lymphocytic activation molecule-associated protein. We describe a patient with a novel missense mutation in SH2D1A. We report on his unique presentation, clinical course and subsequent successful treatment with a matched unrelated donor bone marrow transplant.
引用
收藏
页码:E39 / E42
页数:4
相关论文
共 27 条
[1]   X-linked lymphoproliferative disease associated with hypogammaglobulinemia and growth-hormone deficiency [J].
Alangari, A ;
Abobaker, A ;
Kanegane, H ;
Miyawaki, T .
EUROPEAN JOURNAL OF PEDIATRICS, 2006, 165 (03) :165-167
[2]   X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses [J].
Bassiri, Hamid ;
Yeo, W. C. Janice ;
Rothman, Jennifer ;
Koretzky, Gary A. ;
Nichols, Kim E. .
IMMUNOLOGIC RESEARCH, 2008, 42 (1-3) :145-159
[3]   SAP couples Fyn to SLAM immune receptors [J].
Chan, B ;
Lanyi, A ;
Song, HK ;
Griesbach, J ;
Simarro-Grande, M ;
Poy, F ;
Howie, D ;
Sumegi, J ;
Terhorst, C ;
Eck, MJ .
NATURE CELL BIOLOGY, 2003, 5 (02) :155-160
[4]   Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene [J].
Coffey, AJ ;
Brooksbank, RA ;
Brandau, O ;
Oohashi, T ;
Howell, GR ;
Bye, JM ;
Cahn, AP ;
Durham, J ;
Heath, P ;
Wray, P ;
Pavitt, R ;
Wilkinson, J ;
Leversha, M ;
Huckle, E ;
Shaw-Smith, CJ ;
Dunham, A ;
Rhodes, S ;
Schuster, V ;
Porta, G ;
Yin, L ;
Serafini, P ;
Sylla, B ;
Zollo, M ;
Franco, B ;
Bolino, A ;
Seri, M ;
Lanyi, A ;
Davis, JR ;
Webster, D ;
Harris, A ;
Lenoir, G ;
St Basile, GD ;
Jones, A ;
Behloradsky, BH ;
Achatz, H ;
Murken, J ;
Fassler, R ;
Sumegi, J ;
Romeo, G ;
Vaudin, M ;
Ross, MT ;
Meindl, A ;
Bentley, DR .
NATURE GENETICS, 1998, 20 (02) :129-135
[5]  
Erdos Melinda, 2005, Hum Mutat, V25, P506, DOI 10.1002/humu.9339
[6]   X-linked lymphoproliferative syndrome: An X-cellent question [J].
Filipovich, Alexandra ;
Conley, Mary Ellen ;
Nichols, Kim E. ;
Sullivan, Kathleen E. .
CLINICAL IMMUNOLOGY, 2006, 119 (03) :241-244
[7]  
Gilmour KC, 2000, EUR J IMMUNOL, V30, P1691, DOI 10.1002/1521-4141(200006)30:6<1691::AID-IMMU1691>3.0.CO
[8]  
2-K
[9]   Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein [J].
Halasa, NB ;
Whitlock, JA ;
McCurley, TL ;
Smith, JA ;
Zhu, QL ;
Ochs, H ;
Dermody, TS ;
Crowe, JE .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (10) :E136-E141
[10]  
HARADA S, 1982, J IMMUNOL, V129, P2532